Epcoritamab in Combination with Dose Adjusted EPOCHR for High-risk Burkitt Lymphoma (BL)

Full Title

Epcoritamab in Combination with Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL) (BEDROCK Study) (AMC 119) (CIRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr.Ariela Noy’s office at 646-608-3727.

Protocol
26-388
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
Ariela Noy
Co-Investigators
Raphael Steiner
Diseases
Lymphoma
Lymphoma › Non-Hodgkin's Lymphoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07662928
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description